Signal_NN
transduction_NN
by_IN
DR3_NN
,_,
a_DT
death_NN
domain-containing_NN
receptor_NN
related_JJ
to_TO
TNFR-1_NN
and_CC
CD95_NN
._.

Tumor_NN
necrosis_NN
factor_NN
receptor-1_NN
-LRB-_-LRB-
TNFR-1_NN
-RRB-_-RRB-
and_CC
CD95_NN
-LRB-_-LRB-
also_RB
called_VBN
Fas_NN
or_CC
APO-1_NN
-RRB-_-RRB-
are_VBP
cytokine_NN
receptors_NNS
that_WDT
engage_VBP
the_DT
apoptosis_NN
pathway_NN
through_IN
a_DT
region_NN
of_IN
intracellular_JJ
homology_NN
,_,
designated_VBN
the_DT
``_JJ
death_NN
domain_NN
._.
''_NN

Another_DT
death_NN
domain-containing_JJ
member_NN
of_IN
the_DT
TNFR_NN
family_NN
,_,
death_NN
receptor_NN
3_CD
-LRB-_-LRB-
DR3_NN
-RRB-_-RRB-
,_,
was_VBD
identified_VBN
and_CC
was_VBD
shown_VBN
to_TO
induce_VB
both_CC
apoptosis_NN
and_CC
activation_NN
of_IN
nuclear_JJ
factor_NN
kappaB_NN
._.

Expression_NN
of_IN
DR3_NN
appears_VBZ
to_TO
be_VB
restricted_JJ
to_TO
tissues_NNS
enriched_VBN
in_IN
lymphocytes_NNS
._.

DR3_NN
signal_NN
transduction_NN
is_VBZ
mediated_VBN
by_IN
a_DT
complex_NN
of_IN
intracellular_JJ
signaling_NN
molecules_NNS
including_VBG
TRADD_NN
,_,
TRAF2_NN
,_,
FADD_NN
,_,
and_CC
FLICE_NN
._.

Thus_RB
,_,
DR3_NN
likely_RB
plays_VBZ
a_DT
role_NN
in_IN
regulating_VBG
lymphocyte_NN
homeostasis_NN
._.

